Pernilla Stridh

Karolinska Institutet
Country flagSweden

Research Interests

Explore related searches

Articles (23)

Year:

2025

Objective Specific human leucocyte antigen (HLA) alleles are not only associated with higher risk to develop multiple sclerosis (MS) and other autoimmune diseases, but also with the severity of various viral and bacterial infections. Here, we analyzed the most specific biomarker for MS, that is, the polyspecific intrathecal IgG antibody production against measles, rubella, and varicella zoster virus (MRZ reaction), for possible HLA associations in MS. Methods We assessed MRZ reaction from 184 Swiss patients with MS and clinically isolated syndrome (CIS) and 89 Swiss non‐MS/non‐CIS control patients, and performed HLA sequence‐based typing, to check for associations of positive MRZ reaction with the most prevalent HLA alleles. We used a cohort of 176 Swedish MS/CIS patients to replicate significant findings. Results Whereas positive MRZ reaction showed a prevalence of 38.0% in MS/CIS patients, it was highly specific (97.7%) for MS/CIS. We identified HLA‐DRB1*15:01 and other tightly linked alleles of the HLA‐DR15 haplotype as the strongest HLA‐encoded risk factors for a positive MRZ reaction in Swiss MS/CIS (odds ratio [OR], 3.90, 95% confidence interval [CI] 2.05–7.46, p adjusted = 0.0004) and replicated these findings in Swedish MS/CIS patients (OR 2.18, 95%‐CI 1.16–4.02, p adjusted = 0.028). In addition, female MS/CIS patients had a significantly higher probability for a positive MRZ reaction than male patients in both cohorts combined ( p adjusted <0.005). Interpretation HLA‐DRB1*15:01, the strongest genetic risk factor for MS, and female sex, 1 of the most prominent demographic risk factors for developing MS, predispose in MS/CIS patients for a positive MRZ reaction, the most specific CSF biomarker for MS. ANN NEUROL 2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Karina Banasik

Københavns Universitet

DENMARK
View details

Lina Marcela Diaz-Gallo

Karolinska Institutet

SWEDEN
View details

Ingrid Kockum

Research group leader at Karolinska Institutet

Karolinska Institutet

SWEDEN
View details

Janna Saarela

University of Helsinki

FINLAND
View details

Adil Harroud

McGill University

CANADA
View details

Elaine Kingwell

University College London

UNITED KINGDOM
View details

H S Nielsen

Copenhagen University Hospital

DENMARK
View details

Mette Nyegaard

Aalborg University

DENMARK
View details

Tom Bellander

Healthcare Provision, Stockholm County

SWEDEN
View details

Thomas Folkmann Hansen

Københavns Universitet

DENMARK
View details

Peter Sundström

Umea University

SWEDEN
View details

Kelsi Smith

Karolinska Institutet

SWEDEN
View details

Jonatan Salzer

Lecturer, Consultant neurologist

Umeå University

SWEDEN
View details

Benjamin Vlad

Jena University Hospital

GERMANY
View details

Ilijas Jelcic

-

SWITZERLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.